Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II

Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II

Background. Enzyme replacement therapy (ERT) with iduronate-2-sulfatase recombinant forms (idursulfase and idursulfase beta) is effective for the management of mucopolysaccharidosis type II (MPS II). Patients with Hunter syndrome require lifelong ERT that can negate endogenous enzyme deficiency. How...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Julia G. Levina, Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Elena A. Vishneva, Mariya S. Karaseva, Natalia V. Zhurkova, Kamilla E. Efendieva, Anna A. Alekseeva, Vera G. Kalugina, Artur V. Zaz’yan
Hōputu: Tuhinga
Reo:Ruhiana
I whakaputaina: Union of pediatricians of Russia 2022-07-01
Rangatū:Педиатрическая фармакология
Ngā marau:
mucopolysaccharidosis type ii
hunter syndrome
enzyme replacement therapy
idursulfase
idursulfase beta
drug allergy
urticaria
children
clinical case
Urunga tuihono:https://www.pedpharma.ru/jour/article/view/2178
Tags: Tāpirihia he Tūtohu
No Tags, Be the first to tag this record!
Takiuru mō te puringa me ngā mōhiohio tono whakahoki

Ipurangi

https://www.pedpharma.ru/jour/article/view/2178

Ngā tūemi rite